RRM2 overexpression is commonly associated with chemoresistance by enhancing DNA repair and survival signaling (Gao et al. 2013; Zhan et al. 2021); thus, inhibiting RRM2 could sensitize cancer cells to chemotherapy. The gene discussed is RRM2; the disease is cancer.